🕵️ Sunshine Biopharma Inc. ($SBFM)

SEC insider & ownership activity, last 12 months · CIK 1402328 · every row links its SEC filing

Insiders were quiet over the last 12 months – no open-market buys or sells. L1 Capital Global Opportunities Master Fund, Ltd. added 5.0% → 5.8%. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
Mitchell P. Kopin 10.0% 13GMay 23, 2025 filing ↗
Daniel B. Asher 10.0% 13GMay 23, 2025 filing ↗
Intracoastal Capital LLC 10.0% 13GMay 23, 2025 filing ↗
Bigger Michael 9.5% 13GMay 21, 2026 filing ↗
ALTA Partners LLC 8.6% 13GJul 8, 2026 filing ↗
L1 Capital Global Opportunities Master Fund, Ltd. 5.8% 13GMay 22, 2026 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Material agreement (1.01)Jul 20, 2026 filing ↗
Financial Statements and Exhibits (9.01)Jul 20, 2026 filing ↗
Material agreement (1.01)Jul 8, 2026 filing ↗
Financial Statements and Exhibits (9.01)Jul 8, 2026 filing ↗
Shareholder vote (5.07)May 28, 2026 filing ↗
Material agreement (1.01)May 18, 2026 filing ↗
Other events (8.01)May 18, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 18, 2026 filing ↗
Earnings (2.02)Apr 6, 2026 filing ↗
Financial Statements and Exhibits (9.01)Apr 6, 2026 filing ↗
Other events (8.01)Mar 6, 2026 filing ↗
Financial Statements and Exhibits (9.01)Mar 6, 2026 filing ↗
Shareholder vote (5.07)Feb 18, 2026 filing ↗
Officer/director changes (5.02)Feb 5, 2026 filing ↗
Shareholder vote (5.07)Dec 11, 2025 filing ↗
Auditor change (4.01)Sep 24, 2025 filing ↗
Financial Statements and Exhibits (9.01)Sep 24, 2025 filing ↗